People’s diet quality improved and their abdominal obesity and insulin resistance decreased in a one-year lifestyle intervention, new findings from the Finnish StopDia study show. Looking at 2,907 Finnish adults with an elevated risk for type 2 diabetes, the study is the first to examine the effects of a group-based lifestyle intervention implemented in primary health care on risk factors for type 2 diabetes. The lifestyle intervention made use of a digital app and multiple behaviour change theories. The findings were published in The Lancet Regional Health – Europe.
The StopDia approach was developed in collaboration with multiple stakeholders
In the StopDia study, roughly one hundred health care professionals, including nurses, dieticians and exercise instructors, were trained to use the empowering StopDia group counselling approach.
“The approach is a result of many years of co-creation with health care professionals involved in group counselling, so we knew the approach was well suited to practice, but it was important to have strong evidence on its effectiveness,” says Professor Pilvikki Absetz, who was responsible for the behavioural side of the interventions.
Lifestyle changes were supported by the BitHabit app where participants could choose small health-promoting habits, mark them as completed, and get feedback on their progress. The app’s lifestyle library contains more than 400 habits that are suitable for inclusion in the everyday life. The BitHabit app was developed by VTT Technical Research Centre of Finland in collaboration with the University of Eastern Finland and the Finnish Institute for Health and Welfare as part of the StopDia study.
The StopDia approach to prevent type 2 diabetes was designed and built for primary health care with a view to supporting strategic health promotion objectives. Patient and non-governmental organisations, trade unions, employers and other stakeholders were closely involved in the planning as well as in the recruitment of participants by encouraging people to take a digital type 2 diabetes risk test and to participate in the study. In one year’s time, more than 26,000 people had taken the risk test, and the study recruited adults with an elevated risk for type 2 diabetes.
“It became evident in the course of the study that comprehensive identification of those at risk of type 2 diabetes requires effort from multiple actors, as well as broad collaboration,” says Professor Jussi Pihlajamäki, Director of the StopDia study.
A total of 2,907 study participants in three Finnish hospital districts were randomly divided into three groups: one used the BitHabit app, one used the BitHabit app and received group counselling, and one was a control group. The aim was not to lose weight, but to improve diet quality, increase physical activity, reduce sedentary time, improve sleep, reduce alcohol consumption and stop smoking, thereby reducing the risk for type 2 diabetes.
Diet quality improved, abdominal obesity decreased
In the group using the BitHabit app and receiving group counselling, people’s diet quality improved, they particularly ate more vegetables and better-quality fats, and their waist circumference reduced slightly, whereas similar effects were not observed in the group using the app alone.
“Diet quality in relation to the official nutrition recommendations was assessed using the Healthy Diet Index, which has been developed as part of the StopDia study. The Healthy Diet Index is well suited for promoting lifestyle counselling, and it can also be used as an indicator of effectiveness,” says Research Manager Jaana Lindström from the Finnish Institute for Health and Welfare.
“Better diet quality reduces the risk for type 2 diabetes regardless of changes in the person's weight. Commitment to group counselling and using the BitHabit app enhanced the improvement in diet quality,” Doctoral Researcher Kirsikka Aittola says.
Commitment to using the BitHabit app also increased physical activity and reduced sedentary time.
Using the BitHabit app in combination with group counselling, and even without it, slightly slowed down the development of insulin resistance, which is a precursor of type 2 diabetes.
“Even minor changes may have an impact on the prevention of type 2 diabetes,” says Professor Timo Lakka, Deputy Director of the StopDia study.
It is important to implement lifestyle interventions as part of health care – individual hopes and needs should be acknowledged
“Our findings are important, since this is the first large, randomised, controlled study implemented within primary health care and studying interactions between combined digital and group-based lifestyle counselling,” Jussi Pihlajamäki says.
The findings suggest that commitment to lifestyle counselling, be it digital or group counselling, supports lifestyle changes. Further analyses to be carried out in the study will examine opportunities for delivering increasingly personalised lifestyle counselling.
The risk for type 2 diabetes in the Finnish adult population is high, with up to half a million Finns currently affected. The cost of care per individual diagnosed with type 2 diabetes is estimated at 3,900–8,300 euros per year, depending on comorbidities. The objective of the StopDia lifestyle intervention study was to develop a research-based, cost-effective and permanent model for primary health care to prevent type 2 diabetes. Another objective was for people to recognise their own risk for type 2 diabetes, to be better aware of the possibilities to prevent it, and to get support and services needed to promote healthy lifestyles.
The implementation of the StopDia study was funded by the Strategic Research Council at the Academy of Finland from the Health, Welfare and Lifestyles programme, and its further analyses have also been funded by the Novo Nordisk Foundation and the Diabetes Research Foundation. The study implemented in primary health care was designed by the University of Eastern Finland, the Finnish Institute for Health and Welfare, and VTT Technical Research Centre of Finland, and it was carried out in 2016–2019.
For further information, please contact:
Jussi Pihlajamäki, Director of the StopDia study,
Professor of Clinical Nutrition, Specialist in Internal Medicine, Dean
University of Eastern Finland, Faculty of Health Sciences
jussi.pihlajamaki(a)uef.fi | +358 50 344 0187
https://uefconnect.uef.fi/en/person/jussi.pihlajamaki/
Timo Lakka, Deputy Director of the StopDia study,
Professor of Medical Physiology, Specialist in Internal Medicine
University of Eastern Finland, School of Medicine, Institute of Biomedicine
timo.lakka(a)uef.fi | +358 40 770 7329
https://uefconnect.uef.fi/en/person/timo.lakka/
Pilvikki Absetz,
Professor of Public Health,
Tampere University, Faculty of Social Sciences
pilvikki.absetz(a)tuni.fi | +358 46 921 5112
Jaana Lindström, Research Manager
Master of Food Sciences, PhD, Adjunct Professor
Finnish Institute for Health and Welfare, Population Health Unit
jaana.lindstrom(a)thl.fi | +358 29 524 8635
Kirsikka Aittola, Doctoral Researcher
Master of Health Sciences, Master of Food Sciences, authorised dietician
University of Eastern Finland, Institute of Public Health and Clinical Nutrition, kirsikka.aittola(a)uef.fi, @AittolaKirsikka
https://uefconnect.uef.fi/en/person/kirsikka.aittola/
Research article:
Timo Lakka, Kirsikka Aittola, Elina Järvelä-Reijonen, Tanja Tilles-Tirkkonen, Reija Männikkö, Niina Lintu. Leila Karhunen, Marjukka Kolehmainen, Marja Harjumaa, Elina Mattila, Riia Järvenpää, Miikka Ermes, Santtu Mikkonen, Janne Martikainen, Kaisa Poutanen, Ursula Schwab, Pilvikki Absetz, Jaana Lindström. Jussi Pihlajamäki. Real-world effectiveness of digital and group-based lifestyle interventions as compared with usual care to reduce type 2 diabetes risk – A stop diabetes pragmatic randomised trial. The Lancet Regional Health – Europe. Available online 12 October 2022, 100527
https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(22)00223-X/fulltext#main-menu
Earlier publications on the StopDia recruitment process https://diabetes.jmir.org/2021/3/e21356 and on the Healthy Diet Index https://www.mdpi.com/1660-4601/18/5/2362
StopDia website:
@StopDiaFinland
